Analyst Ratings For NYSE:ZYME – Zymeworks (NYSE:ZYME)
Today, Wells Fargo & Co reiterated its Outperform rating on NYSE:ZYME – Zymeworks (NYSE:ZYME) with a price target of $20.00 ➝ $37.00.
Some recent analyst ratings include
- 6/4/2018-Wells Fargo & Co Reiterated Rating of Outperform.
- 5/14/2018-LADENBURG THALM/SH SH initiated coverage with a Buy rating.
- 5/11/2018-Barclays Upgrade from a “Underweight ➝ Equal Weight” rating to a “” rating.
- 9/30/2017-Cormark Reiterated Rating of Buy.
- 5/23/2017-Citigroup initiated coverage with a Buy ➝ Buy rating.
Recent Trading Activity for NYSE:ZYME – Zymeworks (NYSE:ZYME)
Shares of NYSE:ZYME – Zymeworks closed the previous trading session at 18.55 down -3.31 15.14% with 20.010000228881836 shares trading hands.